Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer

Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Subjects and Methods PART included a QuinteT Recrui...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 122; no. 6; pp. 970 - 977
Main Authors Elliott, Daisy, Hamdy, Freddie C., Leslie, Tom A., Rosario, Derek, Dudderidge, Tim, Hindley, Richard, Emberton, Mark, Brewster, Simon, Sooriakumaran, Prasanna, Catto, James W.F., Emara, Amr, Ahmed, Hashim, Whybrow, Paul, Conte, Steffi, Donovan, Jenny L.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.12.2018
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/bju.14432

Cover

Loading…
Abstract Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Subjects and Methods PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered. Results Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target. Conclusion Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
AbstractList To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered. Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target. Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Subjects and Methods PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered. Results Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target. Conclusion Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
ObjectiveTo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.Subjects and MethodsPART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.ResultsInitially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target.ConclusionAlthough clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.OBJECTIVETo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.SUBJECTS AND METHODSPART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target.RESULTSInitially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target.Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.CONCLUSIONAlthough clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
Author Conte, Steffi
Hindley, Richard
Emara, Amr
Ahmed, Hashim
Rosario, Derek
Hamdy, Freddie C.
Brewster, Simon
Dudderidge, Tim
Leslie, Tom A.
Donovan, Jenny L.
Sooriakumaran, Prasanna
Elliott, Daisy
Catto, James W.F.
Whybrow, Paul
Emberton, Mark
AuthorAffiliation 5 University Hospital Southampton NHS Foundation Trust Southampton UK
9 Imperial Urology Imperial College Healthcare NHS Trust London UK
4 Department of Oncology and Metabolism University of Sheffield Sheffield UK
8 University College London Hospital NHS Foundation Trust London UK
1 Population Health Sciences Bristol Medical School University of Bristol Bristol UK
6 Hampshire Hospitals NHS Foundation Trust Basingstoke UK
2 NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust Bristol UK
3 Nuffield Department of Surgical Sciences University of Oxford Oxford UK
7 Division of Surgery and Interventional Science University College London London UK
AuthorAffiliation_xml – name: 8 University College London Hospital NHS Foundation Trust London UK
– name: 2 NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust Bristol UK
– name: 5 University Hospital Southampton NHS Foundation Trust Southampton UK
– name: 3 Nuffield Department of Surgical Sciences University of Oxford Oxford UK
– name: 1 Population Health Sciences Bristol Medical School University of Bristol Bristol UK
– name: 7 Division of Surgery and Interventional Science University College London London UK
– name: 6 Hampshire Hospitals NHS Foundation Trust Basingstoke UK
– name: 4 Department of Oncology and Metabolism University of Sheffield Sheffield UK
– name: 9 Imperial Urology Imperial College Healthcare NHS Trust London UK
Author_xml – sequence: 1
  givenname: Daisy
  orcidid: 0000-0001-8143-9549
  surname: Elliott
  fullname: Elliott, Daisy
  email: daisy.elliott@bristol.ac.uk
  organization: University of Bristol
– sequence: 2
  givenname: Freddie C.
  surname: Hamdy
  fullname: Hamdy, Freddie C.
  organization: University of Oxford
– sequence: 3
  givenname: Tom A.
  surname: Leslie
  fullname: Leslie, Tom A.
  organization: University of Oxford
– sequence: 4
  givenname: Derek
  surname: Rosario
  fullname: Rosario, Derek
  organization: University of Sheffield
– sequence: 5
  givenname: Tim
  surname: Dudderidge
  fullname: Dudderidge, Tim
  organization: University Hospital Southampton NHS Foundation Trust
– sequence: 6
  givenname: Richard
  surname: Hindley
  fullname: Hindley, Richard
  organization: Hampshire Hospitals NHS Foundation Trust
– sequence: 7
  givenname: Mark
  orcidid: 0000-0003-4230-0338
  surname: Emberton
  fullname: Emberton, Mark
  organization: University College London
– sequence: 8
  givenname: Simon
  surname: Brewster
  fullname: Brewster, Simon
  organization: University of Oxford
– sequence: 9
  givenname: Prasanna
  surname: Sooriakumaran
  fullname: Sooriakumaran, Prasanna
  organization: University College London Hospital NHS Foundation Trust
– sequence: 10
  givenname: James W.F.
  surname: Catto
  fullname: Catto, James W.F.
  organization: University of Sheffield
– sequence: 11
  givenname: Amr
  surname: Emara
  fullname: Emara, Amr
  organization: Hampshire Hospitals NHS Foundation Trust
– sequence: 12
  givenname: Hashim
  surname: Ahmed
  fullname: Ahmed, Hashim
  organization: Imperial College Healthcare NHS Trust
– sequence: 13
  givenname: Paul
  surname: Whybrow
  fullname: Whybrow, Paul
  organization: University of Bristol
– sequence: 14
  givenname: Steffi
  surname: Conte
  fullname: Conte, Steffi
  organization: University of Oxford
– sequence: 15
  givenname: Jenny L.
  surname: Donovan
  fullname: Donovan, Jenny L.
  organization: NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29888845$$D View this record in MEDLINE/PubMed
BookMark eNp9kktvFDEMxyNURB9w4AugSFzgsO1kknldkErFU5V6oRK3KJNx2qwyyTbJbLWfiy-IZ7dbQSXwJZbz8z-242Ny4IMHQl6z4pShnfXL6ZQJwctn5IiJWiwEK34e7P2iqw_JcUrLosBAXb0gh2XXoonqiPy6WkPUYbT-hg7WGKsnly0kem_zLYW7ya6CTUBzoOBV74BG0HGyeQSf56iiUfkBBRIMVAefY3AO3RytcjQYulIxzy4mq2yDp-uEKYPVGFvFkLLKoHMYN9SESCdvEYOIly4gspXdY1QrryG-JM-NcglePZwn5Przpx8XXxeXV1--XZxfLvQ8i8Uw9Iw3rKuEMnXNmpo3nPUNdG3TFkqXqhCmqvoCqloo1fKmapgYas1VaUxjGD8hH3a6q6kfYdDYMdYlV9GOKm5kUFb-fePtrbwJa1lz0QrWocC7B4EY7iZIWeKYNDinPIQpybKoeNnwppvfevsEXYYpemxPloxXbdlhI0i9-bOix1L2_4nA-x2gcWQpgnlEWCHnXZG4K3K7K8iePWG1zdsvwmas-1_GvXWw-be0_Pj9epfxG2N21Vo
CitedBy_id crossref_primary_10_1016_j_eururo_2018_12_030
crossref_primary_10_1016_j_euf_2024_04_008
crossref_primary_10_1177_02692163231197917
crossref_primary_10_1111_bju_15669
crossref_primary_10_1136_bmjopen_2021_051698
crossref_primary_10_1186_s12874_023_02086_1
crossref_primary_10_1002_bjs5_50345
crossref_primary_10_1186_s12874_023_01881_0
crossref_primary_10_1177_1049909119851471
crossref_primary_10_3310_JNZT9406
crossref_primary_10_1016_j_eururo_2022_01_011
crossref_primary_10_1186_s13063_023_07414_w
crossref_primary_10_1186_s13063_020_4227_1
crossref_primary_10_1136_bmjopen_2023_079108
crossref_primary_10_1097_SLA_0000000000005714
crossref_primary_10_1016_j_urolonc_2020_05_010
crossref_primary_10_1111_bju_14918
Cites_doi 10.1186/s13063-016-1391-4
10.1186/s13063-015-0908-6
10.1186/s13063-017-2048-7
10.3310/hta20100
10.1186/s13063-015-0617-1
10.1016/j.cct.2008.03.003
10.1186/1745-6215-12-78
10.1186/s13063-017-2413-6
10.1038/nrclinonc.2014.44
10.1371/journal.pmed.1002147
10.1016/j.jclinepi.2014.03.010
10.1056/NEJMoa1606220
10.1016/j.eururo.2017.04.036
10.1016/j.jclinepi.2008.02.010
10.1038/bjc.2014.313
10.1016/j.eururo.2016.08.044
10.3310/hta19490
ContentType Journal Article
Copyright 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International
2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
BJUI © 2018 BJU International
Copyright_xml – notice: 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International
– notice: 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
– notice: BJUI © 2018 BJU International
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
5PM
DOI 10.1111/bju.14432
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Elliott et al
EISSN 1464-410X
EndPage 977
ExternalDocumentID PMC6348419
29888845
10_1111_bju_14432
BJU14432
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Wellcome Trust
– fundername: Medical Research Council (MRC)
– fundername: Trod Medical
– fundername: Health Technology Assessment (HTA) programme
  funderid: 12/35/54
– fundername: Sophiris Inc.
– fundername: Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
– fundername: Prostate Cancer UK
– fundername: National Institute for Health Research
– fundername: Sonacare Inc.
– fundername: UCLH/UCL NIHR Biomedical Research Centre
– fundername: Medical Research Council
  grantid: MR/K025643/1
– fundername: Department of Health
  grantid: HTA/12/35/54
– fundername: Health Technology Assessment (HTA) programme
  grantid: 12/35/54
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
1OB
7QP
7X8
5PM
ID FETCH-LOGICAL-c4432-ddb1371954af661763731b7e98780ac2a04f55b0e564aa8375714d6c3a2ff7f13
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Thu Aug 21 18:31:02 EDT 2025
Tue Aug 05 11:27:07 EDT 2025
Wed Aug 13 07:26:00 EDT 2025
Mon Jul 21 06:03:16 EDT 2025
Thu Apr 24 23:01:28 EDT 2025
Tue Jul 01 03:50:16 EDT 2025
Wed Jan 22 17:09:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords feasibility
equipoise
qualitative
recruitment
PCSM
ProstateCancer
randomised controlled trial
Language English
License Attribution
2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4432-ddb1371954af661763731b7e98780ac2a04f55b0e564aa8375714d6c3a2ff7f13
Notes Correction added on 18 January 2019 after first online publication: the legal statement and copyright details have been updated in this version
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8143-9549
0000-0003-4230-0338
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.14432
PMID 29888845
PQID 2135829195
PQPubID 1026371
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6348419
proquest_miscellaneous_2053273791
proquest_journals_2135829195
pubmed_primary_29888845
crossref_primary_10_1111_bju_14432
crossref_citationtrail_10_1111_bju_14432
wiley_primary_10_1111_bju_14432_BJU14432
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2018
PublicationDateYYYYMMDD 2018-12-01
PublicationDate_xml – month: 12
  year: 2018
  text: December 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Edgecliff
– name: Hoboken
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2017; 72
2018; 19
2015; 16
2009; 62
2017; 71
2015; 19
2008; 29
2016; 20
2016; 375
2017
2017; 18
2011; 12
2016; 17
2014; 111
2014; 67
2014; 11
2016; 13
1967
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
Hamdy FC (e_1_2_8_8_1) 2017
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
Glaser BG (e_1_2_8_9_1) 1967
References_xml – volume: 72
  start-page: 789
  year: 2017
  end-page: 98
  article-title: Understanding and improving recruitment to randomised controlled trials: qualitative research approaches
  publication-title: Eur Urol
– volume: 29
  start-page: 663
  year: 2008
  end-page: 70
  article-title: Qualitative research to improve RCT recruitment: issues arising in establishing research collaborations
  publication-title: Contemp Clin Trials
– volume: 71
  start-page: 17
  year: 2017
  end-page: 34
  article-title: New and established technology in focal ablation of the prostate: a systematic review
  publication-title: Eur Urol
– volume: 20
  start-page: 1
  year: 2016
  end-page: 201
  article-title: OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
  publication-title: Health Technol Assess
– volume: 19
  start-page: 50
  year: 2018
  article-title: Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework
  publication-title: Trials
– year: 2017
  article-title: A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer
  publication-title: Health Technol Assess
– year: 1967
– volume: 18
  start-page: 327
  year: 2017
  article-title: Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)
  publication-title: Trials
– volume: 19
  start-page: 1
  year: 2015
  end-page: 490
  article-title: Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation
  publication-title: Health Technol Assess
– volume: 12
  start-page: 78
  year: 2011
  article-title: Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)
  publication-title: Trials
– volume: 16
  start-page: 432
  year: 2015
  article-title: A systematic review of training programmes for recruiters to randomised controlled trials
  publication-title: Trials
– volume: 16
  start-page: 88
  year: 2015
  article-title: A simple technique to identify key recruitment issues in randomised controlled trials: Q‐QAT‐quanti‐qualitative appointment timing
  publication-title: Trials
– volume: 111
  start-page: 234
  year: 2014
  end-page: 40
  article-title: Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
  publication-title: Br J Cancer
– volume: 13
  start-page: e1002147
  year: 2016
  article-title: Conveying equipoise during recruitment for clinical trials: qualitative synthesis of clinicians’ practices across six randomised controlled trials
  publication-title: PLoS Med
– volume: 62
  start-page: 29
  year: 2009
  end-page: 36
  article-title: Development of a complex intervention improved randomisation and informed consent in a randomized controlled trial
  publication-title: J Clin Epidemiol
– volume: 67
  start-page: 912
  year: 2014
  end-page: 20
  article-title: The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomised controlled trials
  publication-title: J Clin Epidemiol
– volume: 375
  start-page: 1415
  year: 2016
  end-page: 24
  article-title: 10‐Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
  publication-title: N Engl J Med
– volume: 11
  start-page: 482
  year: 2014
  end-page: 91
  article-title: Can we deliver randomized trials of focal therapy in prostate cancer?
  publication-title: Nat Rev Clin Oncol
– volume: 17
  start-page: 283
  year: 2016
  article-title: Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI)
  publication-title: Trials
– ident: e_1_2_8_6_1
  doi: 10.1186/s13063-016-1391-4
– ident: e_1_2_8_13_1
  doi: 10.1186/s13063-015-0908-6
– ident: e_1_2_8_17_1
  doi: 10.1186/s13063-017-2048-7
– ident: e_1_2_8_15_1
  doi: 10.3310/hta20100
– ident: e_1_2_8_16_1
  doi: 10.1186/s13063-015-0617-1
– ident: e_1_2_8_19_1
  doi: 10.1016/j.cct.2008.03.003
– volume-title: The Discovery of Grounded Theory: Strategies for Qualitative Research
  year: 1967
  ident: e_1_2_8_9_1
– ident: e_1_2_8_20_1
  doi: 10.1186/1745-6215-12-78
– ident: e_1_2_8_11_1
  doi: 10.1186/s13063-017-2413-6
– ident: e_1_2_8_5_1
  doi: 10.1038/nrclinonc.2014.44
– ident: e_1_2_8_10_1
  doi: 10.1371/journal.pmed.1002147
– ident: e_1_2_8_12_1
  doi: 10.1016/j.jclinepi.2014.03.010
– year: 2017
  ident: e_1_2_8_8_1
  article-title: A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer
  publication-title: Health Technol Assess
– ident: e_1_2_8_2_1
  doi: 10.1056/NEJMoa1606220
– ident: e_1_2_8_7_1
  doi: 10.1016/j.eururo.2017.04.036
– ident: e_1_2_8_14_1
  doi: 10.1016/j.jclinepi.2008.02.010
– ident: e_1_2_8_18_1
  doi: 10.1038/bjc.2014.313
– ident: e_1_2_8_3_1
  doi: 10.1016/j.eururo.2016.08.044
– ident: e_1_2_8_4_1
  doi: 10.3310/hta19490
SSID ssj0014665
Score 2.3681207
Snippet Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral...
To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically...
ObjectiveTo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 970
SubjectTerms Ablation
Attitude of Health Personnel
Cancer surgery
Data processing
equipoise
feasibility
Feasibility Studies
Humans
Male
Patient Selection - ethics
Patients
PCSM
Prostate cancer
ProstateCancer
Prostatectomy
Prostatectomy - statistics & numerical data
Prostatic Neoplasms - pathology
Prostatic Neoplasms - therapy
qualitative
Qualitative Research
Radiofrequency Ablation - statistics & numerical data
randomised controlled trial
Randomized Controlled Trials as Topic - methods
Recruitment
Research Subjects - statistics & numerical data
Terminology
Therapeutic Equipoise
Trial
Urological surgery
Title Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.14432
https://www.ncbi.nlm.nih.gov/pubmed/29888845
https://www.proquest.com/docview/2135829195
https://www.proquest.com/docview/2053273791
https://pubmed.ncbi.nlm.nih.gov/PMC6348419
Volume 122
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VHhAX3tCFUg2IA5dUm8SJHXECRFVVKiDESj0gRU5si9CSLJsNEv1b_YPMOA91KUiIvay1GTv2ejwz9oy_AXhujBE6k2HA6VUDYZwOFEO4OqkKpUriAI_EdPwuPVyIo5PkZAtejndhenyI6cCNV4aX17zAddFeWuTF1449kzHLX47VYoPo4wQdRQLAp5Gkb-oC2ekDqhBH8Uw1N3XRFQPzapzkZfvVK6CDW_B57Hofd3K6362L_fL8N1TH_xzbbbg5GKb4quekO7Bl67tw_Xhwvd-Di_fE9NQOqTrkrCoes4O22cgnuWi_d9WyqVqL6watv4-FJEtXXeWj2PlXjaQWDTXQWoNDhPwZFX3eEGwcLpmLqUiVPbvgj5aqeD8SLvlyimaHR_PtJ5KhjV1dERmfqKHXx77ZkQxLZubVfVgcvP305jAYMj4EJY82MKYIY8kgdNqR4UCyT8ZhIW2mpJrrMtJz4ZKkmNskFVrT3jqRoTBpGevIOenC-AFs101tdwCdEUlG9qFJtGKUQSV1qpJUZqXRVkV2Bi_Guc_LAQ6ds3Kc5eO2iCYh95Mwg2cT6bLHAPkT0e7IQPkgBto8CvkickYDmsHT6TH90eyV0bVtOqLh3Bwyllk4g4c9v01viTJFH0G15QYnTgQMDr75pK6-eJDwNBZKhBkN0zPa3zuevz5a-MKjfyd9DDfIcFR9WM8ubK9XnX1Cxtm62INrkfiw59fiL_t2O8A
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9NmwS8jG9WNuBAPPCSqUmc2JF4AcRUxjoktEp7QZETOyIwktI2k8a_xT_InfOhlYGE6Eut5uzY9fnu7Dv_DuC5MUboRPoep1f1hCm0pxjCtZAqUyonDnBITNPjeDITh6fR6Qa87O_CtPgQw4Ebrwwnr3mB84H0pVWefWnYNRmSAN7ijN5uQ_VxAI8iEeASSdI3dYIs9Q5XiON4hqrr2uiKiXk1UvKyBetU0MFN-NR3vo08-brfrLL9_MdvuI7_O7pbsN3ZpviqZabbsGGrO3Bt2nnf78LPD8T31BBpO-TEKg62g3bayIe5aL835bwulxZXNVp3JQtJnC6a0gWy868aSTMaamBpDXZB8mdUdKlDsC5wzoxMRarsOAbPl1TFuZJwzvdTNPs86m8XSLY2NlVJZHyohk4lu2Z7MsyZnxf3YHbw9uTNxOuSPng5j9YzJvNDyTh0uiDbgcSfDP1M2kRJNdZ5oMeiiKJsbKNYaE3b60j6wsR5qIOikIUf3ofNqq7sDmBhRJSQiWgirRhoUEkdqyiWSW60VYEdwYt-8tO8Q0TnxBxnab8zoklI3SSM4NlAOm9hQP5EtNdzUNpJgmUa-HwXOaEBjeDp8Jj-aHbM6MrWDdFweg4ZysQfwYOW4Ya3BImij6Daco0VBwLGB19_UpWfHU54HAol_ISG6Tjt7x1PXx_OXOHhv5M-geuTk-lRevTu-P0u3CA7UrVRPnuwuVo09hHZaqvssVuSvwALCT8E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq48CiPbilgEAcuqTaJEzviRCmrUmhBiJV6QIqc2FZT2iTsbpDav8Uf7IzzULcFCbGXtTZjx15_Ho_t8TcAr7TWXCXC9yi8qse1VZ4kClcrZCZljghwTEwHh_HelO8fRUcr8Ka_C9PyQwwbbjQynL6mAV5re2WQZycNnUyGqH9v8XgsCdK7XwfuKNQALo4kfmMd0FDvaIXIjWfIujwZ3bAwbzpKXjVg3Qw0uQvf-7q3jic_tptFtp1fXKN1_M_G3YM7nWXK3rZQug8rplyHtYPu7P0B_P6MqMdycK5jFFbFkXbgOpvRVi4zP5uiroq5YYuKGXchi6EynTWFc2OnXxXDeVFjAXOjWecif4pJFziEVZbVBGNMYmaHF_ZrjlncQRKr6XaKohOP6uycoaXNmrJAMdpSY25CdsX2YiwnNM8ewnTy_tu7Pa8L-eDl1FpP68wPBbHQKYuWAyo_EfqZMIkUcqzyQI25jaJsbKKYK4WL60j4XMd5qAJrhfXDR7BaVqXZAGY1jxI0EHWkJNEMSqFiGcUiybUyMjAjeN33fZp3fOgUluM07ddF2Amp64QRvBxE65YE5E9CWz2A0k4PzNPAp5vICTZoBC-Gx_hH07GMKk3VoAwF5xChSPwRPG7xNrwlSCR-OOYWS0gcBIgdfPlJWRw7lvA45JL7CTbTAe3vFU939qcusfnvos9h7cvuJP304fDjE7iNRqRsXXy2YHUxa8xTNNQW2TM3IC8BUEo9vA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overcoming+difficulties+with+equipoise+to+enable+recruitment+to+a+randomised+controlled+trial+of+partial+ablation+vs+radical+prostatectomy+for+unilateral+localised+prostate+cancer&rft.jtitle=BJU+international&rft.au=Elliott%2C+Daisy&rft.au=Hamdy%2C+Freddie+C&rft.au=Leslie%2C+Tom+A&rft.au=Rosario%2C+Derek&rft.date=2018-12-01&rft.issn=1464-410X&rft.eissn=1464-410X&rft.volume=122&rft.issue=6&rft.spage=970&rft_id=info:doi/10.1111%2Fbju.14432&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon